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http://dx.doi.org/10.10veterans. Because dementia has a prolonged prodromal phase, understanding effects across the life
course could help focus the timing and duration of prevention targets. This perspective may be espe-
cially relevant for veterans and health behaviors. Military service may promote development and
maintenance of healthy lifestyle behaviors, but the period directly after active duty has ended could
be an important transition stage and opportunity to address some important risk factors. Targeting
multiple pathways in one intervention may maximize efficiency and benefits for veterans. A recent
review of modifiable risk factors for Alzheimer’s disease estimated that a 25% reduction of a com-
bination of seven modifiable risk factors including diabetes, hypertension, obesity, depression, phys-
ical inactivity, smoking, and education/cognitive inactivity could prevent up to 3 million cases
worldwide and 492,000 cases in the United States. Lifestyle interventions to address cardiovascular
health in veterans may serve as useful models with both physical and cognitive activity components,
dietary intervention, and vascular risk factor management. Although the evidence is accumulating for
lifestyle and health-related risk factors as well as military risk factors, more studies are needed to
characterize these factors in veterans and to examine the potential interactions between them.
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Lifestyle and health-related factors represent an important
category of risk factors for cognitive aging among veterans.
Evidence is emerging supporting an association between
several health factors and behaviors with risk of cognitive
impairment and dementia including cardiovascular risk fac-
tors, physical and cognitive activity, nutrition, sleep quality,
and smoking and alcohol use. Although veterans may be at
increased risk of cognitive aging because of a unique set of
military-related exposures [1], some lifestyle and health-
related risk factors may also be elevated in veterans such as
smoking and sleep disturbances [2,3]. It is estimated that in
the general population, lifestyle and health-related risk fac-
tors may contribute to almost half of dementia cases [4],imer’s Association.
Table 1
Prevalence of lifestyle and health-related risk factors among veterans
Risk factor
Prevalence
in veterans (%) Data sources
Cardiovascular risk factors
Hypertension 36.8 1991–2001 VA Health Care
System [8]
Dyslipidemia 29.5 1998–2001 VA Health Care
System [10]*
Diabetes 15.6 1991–2001 VA Health Care
System [8]
Obesity 37.4 2000 VA Health Care System
[158]
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risk factors could be a critical component of understanding
risk of cognitive aging in veterans and developing effective
dementia prevention strategies. This review will present the
supporting evidence for major lifestyle and health-related
risk factors for cognitive impairment and dementia (other
military-related exposures and mental health risk factors
will be reviewed elsewhere in this issue) and discuss the prev-
alence of these risk factors in veteran populations.Many life-
style and health-related risk factors may emerge as a
consequence of military service including behaviors that
are potentially modifiable during active duty service.Metabolic
syndrome
25.0 2004–2005 VANCHCS [40]
Physical activity
Meets
recommended
guidelinesy
45.1 2003 BRFSS [50]z
Sleep quality
Insufficient sleep 22.7 2009 BRFSS [3]z
Sleep apnea 2.9 1998–2001 VA Health Care
System [159]
Alcohol use
Alcohol misusex 25.0 2005 EPRP Medical Record
Reviews [160]
Smoking
Current smoking 19.7 2011 VA Survey of Enrollees
[161]
Nicotine
dependence
14.9 2008–2009 VA Health Care
System [162]
Abbreviations: VA, Veteran Affairs; VANCHCS, Veteran Affairs North-
ern California Health Care System; BRFSS, Behavioral Risk Factor Surveil-
lance System; EPRP, External Peer Review Program of VA Medical
Records.
*Data from six VA acute care medical centers.
yMeeting physical activity recommendations indicates 30 minutes of
moderate activity on 5 d/wk or 20 minutes or more of vigorous activity
on 3 d/wk.
zVeterans who reported using VA Health Care.
xAlcoholmisuse indicates positive screen onAlcohol Use Disorders Iden-
tification Test (AUDIT) or AUDIT-Consumption.2. Cardiovascular risk factors
A number of critical cardiovascular and metabolic risk
factors have demonstrated strong relationships with cogni-
tive decline and dementia, including hyperlipidemia, hy-
pertension, and diabetes [5,6]. In epidemiologic studies,
midlife vascular risk factors have been consistently
associated with a risk of late-life dementia [5,7].
Estimates of these chronic conditions among veterans
vary, but in one study of veterans using VA health-care
data, 16% had diabetes and 37% had hypertension [8],
the prevalence of dyslipidemia was estimated to be between
25% and 36% (Table 1) [9,10]. A comparison of veterans
with nonveterans from the National Health and Nutrition
Examination Survey indicates that the prevalence of
hypertension was not significantly different between the
two groups [11].
In observational studies, high blood pressure in midlife
has been associated with an increased risk for both vascular
dementia and Alzheimer’s disease (AD) [12,13].
Hypertension may affect cerebral blood flow and increase
vascular brain injury [14–16]; there is also evidence from
mice models and epidemiologic studies to suggest that
hypertension interferes with b-amyloid clearance [17,18].
An increasing number of studies also indicate that
hypotension in late life could increase dementia risk
because of the effects on cerebral blood flow [19]. Data
from blood pressure treatment trials, such as Action in
Diabetes and Vascular Disease (ADVANCE), Hypertension
in the Very Elderly cognitive function assessment
(HYVET-COG) and the Study on Cognition and Prognosis
in the Elderly (SCOPE), vary with some demonstrating a
benefit for dementia prevention and others reporting no
effects, which may be a result of differences in the class
of drugs used for hypertension therapy [20]. To further un-
derstand the effects of blood pressure treatment, the
ongoing National Institutes of Health (NIH)–funded Sys-
tolic Blood Pressure Intervention Trial will monitor the
course of cognitive decline with intensive blood pressure
control [21].
Data from observational cohort studies indicate that high
cholesterol levels could increase the risk of dementia, andboth neuropathologic and observational studies of patients
on statin therapies correspond with these findings [22].
High cholesterol may increase dementia risk by increasing
production of b-amyloid and increasing b-amyloid aggrega-
tion, but few studies have distinguished between the effects
of specific lipids such high- or low-density lipoproteins
[22,23]. Translation of these findings to prevention
interventions has been challenging as most randomized
controlled trials have not resulted in any benefits from
statin therapy [23]; however, the lack of positive results
could be related to issues of blood-brain barrier permeability
and timing of therapy [23].
The consistent observation that diabetes is associated
with an increased risk of dementia could be the result of
several pathways including disruption of insulin signaling
necessary for brain function, increased accumulation of
advanced glycation end products, and interference with
b-amyloid clearance [24]. Meta-analyses suggest that the
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betes compared with those without diabetes [24,25].
Among older adults, diabetes is associated with a range
of magnetic resonance imaging (MRI) outcomes
including increased brain atrophy [26], increased ischemic
lesions [27], and lower fractional anisotropy in white
matter and greater diffusivity in regions such as the hippo-
campus [28]. Investigations of markers of glucose control
suggest that there may be a U-shaped association with
cognitive impairment in which both hyperglycemia and
hypoglycemia are associated with an increased risk of
dementia [29]. Preliminary treatment trials with intranasal
insulin have been encouraging with studies reporting
positive effects for cognition in patients with cognitive
impairment [30].
The association between obesity and increased risk of
dementia might be related to its role as a marker of
vascular and inflammatory damage. In addition, adipose
tissues secrete inflammatory proteins such as leptin,
which could affect neurodegeneration [31]. Behavioral
Risk Factor Surveillance System (BRFSS) data indicate
that similar to the general population, rates of obesity in
veterans are a concern [32,33]. Almost one-quarter of vet-
erans meet the criteria for obesity, whereas more than half
are overweight [33,34]. Although few studies have
focused solely on weight loss for dementia prevention, a
meta-analysis of weight loss trials reported benefits for
attention and executive function primarily in obese sub-
groups; however, long-term randomized controlled trials
are needed to determine the effectiveness of such inter-
ventions [35].
The metabolic syndrome, composed of several of the risk
factors described previously, is another cardiovascular risk
factor with strong evidence of an association with cognitive
impairment and dementia [6,36,37]. Metabolic syndrome is
defined as having at least three of the following five risk
factors: abdominal obesity, high triglycerides, low high-
density lipoprotein cholesterol level, high blood pressure,
and high fasting blood glucose [38]. In 2006, it was esti-
mated that among veterans without diabetes, 2 million
may have the metabolic syndrome [39], and evaluation of
data from the Veterans Affairs Northern California Health
Care System found that 25% of veterans met the criteria
for metabolic syndrome [40]. Several studies have identified
an interaction between the metabolic syndrome, inflamma-
tion, and increased risk of cognitive impairment [6,41,42],
and in a small study of community-dwelling older adults,
metabolic syndrome was associated with microstructural
changes in the brain, including magnetization transfer ratio
peak height and diffusivity [43].
In general, the prevalence of cardiovascular risk factors
in veterans is not elevated compared with nonveteran pop-
ulations, but there may be subgroups of veterans that have
higher prevalences of these risk factors, in particular those
with a mental health diagnosis. Among Iraq andAfghanistan veterans enrolled in VA Health Care, those
with a mental health diagnosis including posttraumatic
stress disorder (PTSD), depression, adjustment disorders,
anxiety, and substance and alcohol use disorders were
more likely to have hypertension, hyperlipidemia, and
obesity [44]. PTSD, in particular, may also be associated
with greater likelihood of obesity and overweight as
well as the metabolic syndrome [45,46]. Chronic stress
could alter several pathways such as the hypothalamic-
pituitary-adrenal axis and the sympathetic nervous system
leading to increased risk of cardiovascular disease [47]. In
addition, other exposures associated with military service
such as combat experience and Agent Orange exposure
have been associated with elevated levels of cardiovascu-
lar risk factors [48,49].3. Physical activity
Although active duty military members report high
participation in physical activity, studies indicate that veter-
ans do not maintain comparable levels of activity after mil-
itary service [50,51]. Only 45% to 50% of veterans meet
guidelines for sufficient physical activity, roughly similar
to the percentages meeting recommended guidelines in
nonveteran populations [50,52]. Furthermore, although
most veterans recognize the importance of physical
activity, they also report additional barriers to regular
physical activity participation related to their military
service including depression, injuries, and chronic pain
[53,54]. Enforced body composition and fitness standards
during military service [55] do not translate into postmilitary
habits, and retirees have a prevalence of obesity at least com-
parable with their civilian peers [56]. The upper limit of
permissible body fat in active duty service members older
than 40 years is 26% and 36% for men and women, respec-
tively, and some of the military services have more stringent
limits [57]. These upper limits coincide with median values
for body fat in the US nonmilitary population surveyed in the
National Health and Examination Survey [58] indicating
that half of older Americans would be too fat for active
duty. The similarity of obesity rates between retired military
and civilian population is particularly striking and supports
the perception that there may be an increased risk for major
weight gain within the first year of retirement from active
duty. Such an effect of large overshoot body fat gain after ex-
ercise cessation has been observed in rodent models [59,60].
This concept of “retirement obesity” in veterans is a topic of
current research interest specifically called out in a request
for proposals from the National Institute of Diabetes and
Digestive and Kidney Diseases.
As a protective health factor, physical activity may
decrease the risk of cognitive aging by increasing oxygen
saturation and neurogenesis and decreasing vascular risk
factors, inflammation, and depressive symptoms [61,62].
In one study of older adults, habitual physical activity
Table 2
Summary of neuroprotective nutrients
Nutrient Possible mechanism
Oleocanthal Prevent aggregation of tau protein and reduce
b-amyloid
Omega-3 fatty acids Moderate chronic microglial inflammatory
responses
Protect against oxidative damage
Epigallicatechin Hippocampal neurogenesis
Anti-inflammatory
Reduce b-amyloid and tau aggregation
Caffeine Antagonize the A2A adenosine receptor
Potentiate BDNF action in the hippocampus
Protect against oxidative damage
Choline Acetylcholine precursor
Vitamins C and E Protect against oxidative damage
Reduce b-amyloid toxicity
Folate Moderate plasma homocysteine
Abbreviation: BDNF, brain-derived neurotrophic factor.
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and amyloid deposition in the brain, but conflicting
results were reported by another study of older adults
(cognitively normal or with mild cognitive impairment)
[63,64]. A meta-analysis of prospective studies in nonde-
mented older adults found that not only were high levels
of physical activity protective against cognitive decline,
but low-to-moderate activity levels were also protective
[65]. Similar results were reported for a meta-analysis
examining physical activity and risk of dementia [66]. In
concordance with these findings, imaging studies also sug-
gest that physical activity is associated with beneficial ef-
fects on brain structure [67] including increased gray
matter volume [68] and better measures of white matter
integrity (lower diffusivity and higher fractional anisot-
ropy) [69,70], whereas low physical activity has been
associated with increased brain atrophy [71].
Evidence from randomized controlled trials indicates that
both aerobic exercise and resistance training could delay
cognitive decline [72]. The findings from randomized
controlled trials are still just emerging, but physical activity
interventions in older adults have reported benefits for exec-
utive function, processing speed, delayed memory, and
attention; positive effects have been shown for patients
with mild cognitive impairment in particular [72].4. Neuroprotective nutrition
In 2011, the Committee on Military Nutrition Research
(CMNR) completed an important analysis of nutritional fac-
tors influencing susceptibility, protection, and recovery from
military traumatic brain injury. This was intended to be only
the first phase of a larger strategic assessment of neuropro-
tective nutrition, but, with the advent of new defense budget
cuts, this became the last funded effort of this standing com-
mittee at the Institute of Medicine that has advised the
Department of Defense on military nutrition research for
25 years. The comprehensive 431-page report provided an
expert assessment of the state of knowledge and made rec-
ommendations for further investigation in neuroprotection
[73]. Many of the same nutrients and supplements recom-
mended for further research by the CMNR have emerged
as potential disease modifiers in associational studies of
AD and dementia, including n-3 fatty acids, flavonoids, an-
tioxidants, and choline.
Some of these AD associations have also been supported
by plausible mechanisms and have been explored in animal
studies, but none of these nutrients and dietary components
has been properly evaluated in randomized prospective
studies. Part of the reason for this is that randomized
controlled trials are expensive and failure of an expensive
trial reduces willingness to embark on new trials, but there
are other complications with nutrition studies. One of the
advantages of nutritional modifiers of disease is that these
tend to be affordable changes in normal behaviors rather
than involving pharmaceutical treatments that invariablycarry undesirable side effects, but the disadvantages are
in being able to conduct studies of potentially large health
impacts that may only be accrued through long-term habits
(e.g., antioxidant intakes) and may interact with other be-
haviors such as activity patterns. Action on these important
recommendations from the CMNR and for nutrients with
potential benefit to disease modification for AD and de-
mentia will depend on federal funding (e.g., NIH, US
Department of Agriculture, and VA) as there is generally
little commercial incentive in promoting health applica-
tions for foods relative to the investment incentive in phar-
maceuticals.
Key components of the Mediterranean diet have biolog-
ically plausible mechanisms for suspected neuroprotective
benefits that have been demonstrated in some epidemio-
logic studies (Table 2) [74]. The potent anti-inflammatory
properties of oleocanthal, a component of extra virgin olive
oil that was identified through its similar throat irritant
properties, may offer a partial explanation for the benefits
of the Mediterranean diet in AD and have been shown to
prevent aggregation of tau protein and reduced b-amyloid
accumulation in mice [75,76]. Similarly, omega-3 fatty
acids found in high concentration in many fish are precur-
sors for resolvins and protectins that may be important
moderators of chronic microglial inflammatory responses
to brain insults [77]. This may help to explain the lower
prevalence of AD in countries with the highest fish con-
sumption [78]. Epigallicatechin (EGC) has been much
investigated as one of the important polyphenols in dark
chocolate and green tea, two foods associated with health
benefits and specific effects on hippocampal neurogenesis
[79]. The effects of flavonoids such as EGC appear to be
anti-inflammatory but may also involve neuronal signaling,
with effects on brain-derived neurotrophic factor (BDNF)
and other factors affecting memory, learning, and cognition
[80]. In transgenic AD mice, EGC reduced b-amyloid and
tau aggregation [81]. Caffeine in coffee and other foods has
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through antagonism of the A2A adenosine receptor and with
actions that range from potentiation of BDNF action in the
hippocampus to neuroprotective antioxidant activity
[82,83]. Drinking three to five cups of coffee per day was
associated with a decreased risk of dementia and AD in a
Finnish cohort [84]. Transgenic AD mouse studies demon-
strate caffeine protective and restorative benefits for mem-
ory and reduced b-amyloid accumulation [85]. Animal
studies of oleocanthal, EGC, caffeine, and omega-3 fatty
acids suggest antiamyloidogenic properties of these nutri-
ents and possibly synergistic effects of some combinations
[86]. Choline has long been pursued in research for neuro-
physiological effects in the cholinergic system; when com-
bined with an omega-3 fatty acid and uridine in a drink
form, the combination improved memory after administra-
tion to patients with early AD for 6 months [87]. Fruits and
vegetables in the Mediterranean diet, such as berries and
grapes, also provide antioxidant vitamins and nutrients.
Reactive oxygen species are involved in neuronal damage
and brain aging. Long-term antioxidant nutrition, in the
form of supplements with Vitamins C and E in combina-
tion, has been associated with substantially reduced risk
for AD compared with no supplement use, suggesting the
possibility that antioxidants in the diet could delay AD
onset [88]. Folate has also been considered for its role in
moderating plasma homocysteine, which has strong associ-
ations as a risk factor for dementia and AD, and folate-
deficient diets may increase AD risk [89,90].
The single identified neuroprotective dietary compo-
nent in the US military diet is caffeine, which is ingested
in high amounts estimated at a mean consumption rate of
285 mg/d, primarily in the form of coffee; 82% of sol-
diers consumed caffeine at least weekly. In the US mili-
tary, caffeine is even provided in a chewing gum
formulation in the First Strike Ration [91]. Service mem-
bers are not prominent consumers of the nutrients and
other dietary components that tend to be neuroprotective.
For example, they tend to have diets low in omega-3 fatty
acids as fish is not a popular meal, and except for one
special meal with salmon (Kosher for Passover), there is
no fish entree in any operational rations. Vitamin use,
including multivitamins that would usually include anti-
oxidant levels of Vitamins C and E, does have a relatively
high prevalence in service members, with half of all sol-
diers using a dietary supplement, including more than
one-third of soldiers using a multivitamin [92]. This sug-
gests opportunities for future neuroprotective nutrition de-
signs of military operational rations with potentially high
impact in modifying acute and long-term brain health and
performance.5. Cognitive and social activity
The likely protective effects of cognitive activity have
given rise to the concept of cognitive reserve in which fac-tors such as education could buffer the effects of neuropath-
ologic damage associated with dementia. In a study ofWorld
War II veterans, participants reporting more intellectually
demanding jobs had better cognitive performance in late
life [93], and in a cohort of male twins from the National
Academy of Sciences-National Research Council Twin Reg-
istry of World War II veterans and participants in the Duke
Twins Study of Memory in Aging, midlife cognitive activity
was associated with lower risk of dementia [94]. Cognitive
engagement in activities such as games, puzzles, or reading
has also been associated with lower risk of cognitive decline
and dementia in elderly populations [95]. Furthermore, in a
study of older adults, the effect of plasma b-amyloid on
cognitive decline was attenuated by cognitive reserve
(defined as a higher level of education or literacy) [96],
and neuropathologic studies indicate that cognitive activity
may increase neuronal density and cortical thickness
(compensation), modifying the effects of cerebrovascular
disease and increasing brain mass [97]. Similarly, one study
found that the effects of educational attainment were more
strongly associated with cognitive ability in late life than
neurodegenerative pathology (measured by white matter in-
tensities and hippocampal atrophy) [98]. Cohort studies also
indicate that frequent cognitive activity could compensate
for the effects of lower education [99], whereas lifetime
cognitive activity was associated with lower amyloid
deposition (early and midlife) in a small cross-sectional
study [100].
Randomized controlled trials in both healthy and
impaired individuals indicate that cognitive training
may be beneficial and suggest that interventions targeting
multiple domains may be better than those focused on a
single domain, but the effects on dementia risk are still
not confirmed [101]. Cognitive training in older adults
over 12 weeks demonstrated benefits for cerebral blood
flow, network connectivity, and white matter integrity
[102].
Like cognitive activity, higher levels of social engage-
ment and social networks have also been associated with
lower cognitive decline and reduced risk of dementia in
observational studies [103]. The benefits of social engage-
ment may be linked to the mechanisms of cognitive reserve.
Social activities could increase cognitive stimulation as well
as enhance social support and influence. However, reverse
causality may also be an underlying factor for this observed
association. As dementia progresses, patients may be less
able to engage in social activity [104]. Nevertheless, several
long-term prospective studies with follow-up times of over a
decade have also demonstrated similar protective relation-
ships between social engagement and risk of dementia in
both mid- and late life [105]. One MRI study suggests that
high social engagement is associated with greater total brain
and gray matter volumes [106]. There is some evidence from
trials to suggest that increased engagement in social activity
could be effective in lowering risk of cognitive decline and
dementia [107,108].
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tive role for cognitive reserve and decreased risk of other
psychiatric disorders including PTSD, major depression,
and major anxiety disorder [109,110]. Similarly, higher
levels of social support are associated with reduced risk of
psychiatric comorbidities [111], but more studies are needed
to understand the potential impact of cognitive and social ac-
tivities on veterans’ risk of dementia.6. Sleep quality
Sleep disturbances are a major concern for veterans. In a
recent study of active duty military personnel attending
treatment facilities, one-quarter were diagnosed with mild
obstructive sleep apnea and another quarter had
moderate-to-severe apnea, whereas almost one-fourth of
the sample also met criteria for insomnia, and 40% reported
short sleep duration (,5 hours of sleep per night) [112].
Data from the BRFSS indicate that veterans are more likely
to report sleep disturbances (not enough sleep and short
sleep) compared with nonveterans [3], and in an observa-
tional study, older veterans also reported more sleepiness
than controls [113].
Sleep quality is a critical emerging risk factor for cogni-
tive aging [114]. Measures of sleep quality such as exces-
sive daytime sleepiness, sleep duration, and sleep latency
have been associated with dementia and cognitive impair-
ment [115–117]. Disturbed sleep could affect synaptic
plasticity and consolidation of memory [118–120]. Data
from rodent models suggest that b-amyloid clearance
may also occur during sleep, possibly mediated through
aqueporin 4 [121,122]. A survey of veterans indicates
that insufficient sleep and fatigue are common, but many
veterans may not be receiving treatment for these
symptoms [123].
Evidence is also accumulating for sleep-disordered
breathing as a risk factor for cognitive impairment and de-
mentia. Cross-sectional studies suggest that cognitive per-
formance is worse in those with sleep-disordered breathing
[124–126], and in a prospective study of older adults,
sleep-disordered breathing was associated with an increased
risk of dementia [127]. Sleep-disordered breathing has also
been associated with decreased white matter integrity and
lower gray matter volume [128,129].
Circardian rhythms are another characteristic of sleep
that may be associated with cognitive impairment. Disrup-
tions in circadian rhythms may be common during military
service [130], and there is some evidence to suggest circa-
dian variation in heart rate variability as it relates to auto-
nomic dysfunction in Gulf War Illness [131,132], but
little is known about circadian disturbances in sleep
among veterans. In older adults, altered circadian
rhythms, including decreased amplitude and robustness as
well as shifted time of peak activity, have also been
associated with higher risk of developing dementia [133].
Like cardiovascular risk factors, sleep disturbances, sleep-disordered breathing, and circadian rhythm alterations are
associated with psychiatric comorbidities including PTSD
[134–137].7. Alcohol and smoking
Both alcohol and smoking are important lifestyle risk
factors that could significantly affect dementia risk, and
veterans may be more likely to engage in some of these
behaviors [51]. Neuroimaging studies indicate that smok-
ing may lead to both macro- and microvascular cerebral
damage [14,138]. A meta-analysis of prospective studies
indicates that compared with nonsmokers, current
smokers had higher rates of cognitive decline and
increased risk of dementia; however, former smokers did
not have an increased risk of dementia compared with
nonsmokers [139].
In contrast to smoking, studies have reported that there
may be a J-shaped curve in risk associated with alcohol con-
sumption such that moderate alcohol consumption is more
protective than no consumption, but heavy alcohol con-
sumption is associated with an increased risk of dementia
[140]. A meta-analysis of epidemiologic studies found that
moderate alcohol use was associated with decreased risk
of AD and any dementia [141]. Proposed pathways of bene-
ficial effects may be related to lowering lipid levels, modi-
fying hormone levels, or, in the case of wine, antioxidant
effects [142], but chronic alcohol abuse could be neurotoxic
and increase risk of dementia [143].
Data from the BRFSS indicate that overall, veterans may
not have riskier alcohol consumption patterns compared
with nonveterans [144] but that specific groups such as older
veterans and veterans who are college students may engage
in riskier consumption patterns including heavy and binge
drinking [144,145]. Similar population-based surveys also
suggest that rates of smoking tend to be higher among veter-
ans compared with nonveterans [2,51]. Results from the
BRFSS indicate that the age-adjusted prevalence of current
smoking was 27.0% among veterans, but the prevalence
was even higher among younger veterans, between 36%
and 40%, whereas the prevalence of smoking among
younger nonveterans was between 22% and 30% [2]. Veter-
ans with mental health diagnoses are also more likely to
smoke [146].8. Conclusion
In the United States, almost 60% of veterans are older
than 60 years [147], and by 2030, projections suggest that
there will be .7 million veterans older than 65 years
[148]. As a result, cognitive impairment and dementia could
have a significant impact on veterans’ health-care costs and
caregiver burden. Although military-related risk factors are
an integral component in determining the risk of cognitive
aging among veterans, lifestyle and health factors are also
critical. Veitch et al. [149] estimated that by the year 2020,
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able to obesity, 75,000 to hypertension, 49,000 to dyslipide-
mia, 51,000 to low physical activity, 19,000 to diabetes, and
55,000 to smoking.
Because dementia has a prolonged prodromal phase, un-
derstanding effects across the life course could help focus
the timing and duration of prevention targets. This perspec-
tive may be especially relevant for veterans and health be-
haviors. Studies suggest that the prevalence of certain
health behaviors fluctuate over the life course, and although
military service may impact the development and mainte-
nance of healthy lifestyle behaviors [52,150], the period
directly after active duty has ended could be an important
transition stage to begin to address some of these risk
factors [151,152].
Targeting multiple pathways in one intervention may
maximize efficiency and benefits for veterans. A recent re-
view of modifiable risk factors for AD estimated that a
25% reduction of a combination of seven modifiable risk
factors including diabetes, hypertension, obesity, depres-
sion, physical inactivity, smoking, and education/cogni-
tive inactivity could prevent up to 3 million cases
worldwide and 492,000 cases in the United States [4].
Lifestyle interventions to address cardiovascular health
in veterans may serve as useful models including the
Self-Management to Prevent Stroke Program [153], PO-
WER, an intervention of peer leaders to control hyperten-
sion [154], and MOVE!, a weight loss program [155]. A
small number of randomized controlled trials have started
to test the efficacy of multidomain interventions in general
populations. These include the Finnish Geriatric Interven-
tion Study to Prevent Cognitive Impairment and Disability
with physical and cognitive activity components, dietary
intervention, and vascular risk factor management and
the Multidomain Alzheimer Preventive Trial, which will
test omega-3 supplementation and a multidomain inter-
vention with cognitive training, physical training,
and nutritional education [156]. The Prevention of
Dementia by Intensive Vascular Care study will target
multiple vascular risk factors including hypertension and
hyperlipidemia through primary care management and
counseling [157].Demographic Risk Factors
Lifestyle & Health Related Risk Factors
Genec Risk Factors
Risk of Cognive Aging  
Among Veterans
Military Related Risk Factors
Fig. 1. Proposed risk factors for cognitive aging among veteran populations.A number of issues must be investigated to fully under-
stand the full spectrum of risk factors for cognitive aging
in veterans (Fig. 1). The demographics of the veteran pop-
ulation continue to change with increasing racial/ethnic
and gender diversity, and over time, aging cohorts of vet-
erans may reflect different exposures and risk factors asso-
ciated with service in different wars [148]. In addition,
broad population trends toward sedentary lifestyles, and
an increased risk of obesity could be an important factor
for upcoming generations of veterans. As demonstrated
by Barnes and Yaffe [4], the prevalence of these various
risk factors in different populations could play an impor-
tant role in evaluating risk and determining prevention tar-
gets. Although evidence is accumulating for lifestyle and
health-related risk factors as well as military risk factors,
more studies are needed to characterize these factors in
veterans and to examine the potential interactions between
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